{
    "clinical_study": {
        "@rank": "99326", 
        "arm_group": [
            {
                "arm_group_label": "Control group and intermittent fasting", 
                "arm_group_type": "Other", 
                "description": "Usual western diet for 8 weeks, followed by 8 weeks of usual diet with intermittent fasting."
            }, 
            {
                "arm_group_label": "Mediterranean diet and intermittent fasting", 
                "arm_group_type": "Experimental", 
                "description": "Mediterranean diet for 8 weeks, followed by 8 weeks of Mediterranean diet with intermittent fasting."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study is to evaluate the effects of intermittent fasting in\n      subjects that are eating a Mediterranean diet or a Western diet. This study is part of\n      ongoing research in the prevention and treatment of age-related diseases at Washington\n      University School of Medicine."
        }, 
        "brief_title": "Short Term Intermittent Fasting and Mediterranean Diet", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Overweight", 
            "Pre-hypertension", 
            "Hypertension", 
            "Hypercholesterolemia", 
            "Glucose Intolerance", 
            "High Risk Waist Circumference"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypercholesterolemia", 
                "Hypertension", 
                "Glucose Intolerance", 
                "Overweight", 
                "Prehypertension"
            ]
        }, 
        "detailed_description": {
            "textblock": "The primary objective of this study is to determine whether or not IF, independently of\n      changes in quality of diet, reduces the level of chronic inflammation as evidenced by a\n      decrease in high sensitivity C-reactive protein (hsCRP), as the main outcome measure."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. - The participants in this study will be 40 men and women in the 30 to 65 year age\n             range, who have a BMI in the high-normal to moderately overweight  range (i.e. 22 to\n             28 kg/m2),\n\n          2. - Participants who are eating usual US diets and are sedentary to moderately active\n             (i.e. not exercise trained).\n\n          3. - Participants have at least one of these metabolic abnormalities: pre-hypertension\n             or hypertension (i.e. systolic blood pressure > 120 mmHg or diastolic blood pressure\n             > 80 mmHg or specific treatment of previously diagnosed hypertension)10, sub-optimal\n             lipid levels (i.e. LDL-cholesterol > 100 mg/dl or HDL-cholesterol < 59 mg/dl or\n             specific treatment for this lipid abnormality)11, impaired fasting glucose or glucose\n             intolerance (i.e. fasting glucose > 100 mg/dl or 2 hr-glucose during OGTT with a\n             glucose load of 75 g > 140 mg/dl or specific treatment for previously diagnosed type\n             2 diabetes)12, or high-risk waist circumference (\u2265 94 cm in men and \u2265 80 cm in\n             women)13.\n\n        Exclusion Criteria:\n\n        - 1 - History of any chronic disease process that could interfere with interpretation of\n        results 2 - Smoking, pregnancy, alcoholism, psychiatric problems, life situations that\n        would interfere with study participation and compliance.\n\n        3 - Currently eating diet similar to Mediterranean diet based on dietary and food\n        frequency questionnaires and 4-day food diary."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02148458", 
            "org_study_id": "201404045"
        }, 
        "intervention": [
            {
                "arm_group_label": "Mediterranean diet and intermittent fasting", 
                "description": "Mediterranean diet for 8 weeks, followed by 8 weeks of Mediterranean diet with intermittent fasting (i.e.  2 non-consecutive days of fasting per week)", 
                "intervention_name": "Mediterranean diet and intermittent fasting", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control group and intermittent fasting", 
                "description": "control group eating their usual Western diet for 8 weeks, followed by 8 weeks of usual diet with intermittent fasting (i.e. 2 non-consecutive days of fasting per week).", 
                "intervention_name": "Control group and intermittent fasting", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Intermittent fasting", 
            "Mediterranean diet", 
            "overweight", 
            "Calorie restriction"
        ], 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "contact": {
                "email": "sjamalab@dom.wustl.edu", 
                "last_name": "Shohreh Jamalabadi-Majidi, DMD, MPH", 
                "phone": "314-362-2399"
            }, 
            "facility": {
                "address": {
                    "city": "St Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110"
                }, 
                "name": "Washington University School of Medicine"
            }, 
            "investigator": {
                "last_name": "Luigi Fontana, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Metabolic and Molecular Effects of a Mediterranean Diet and Intermittent Fasting", 
        "overall_contact": {
            "email": "sjamalab@dom.wustl.edu", 
            "last_name": "Shohreh Jamalabadi-Majidi, DMD, MPH", 
            "phone": "314-362-2399"
        }, 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Luigi Fontana, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "hsCRP  is in mg/L", 
            "measure": "Decrease in high sensitivity C-reactive protein (hsCRP)", 
            "safety_issue": "No", 
            "time_frame": "16 weeks-- Baseline, 8 weeks, 16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02148458"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}